Pavol Kral
Bratislava, BL, Slovakia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
How enzalutamide affects sex life and how taking a break from treatment affects quality of life: a plain language summary of results from the EMBARK study in people with hormone-sensitive prostate cancer and high-risk biochemical recurrence.
Journal: Future oncology (London, England)
Published: July 06, 2026
Treatment and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer by Race, Initial Diagnosis, and Family History: Results From the TRUMPET Registry.
Journal: Clinical genitourinary cancer
Published: December 11, 2025
Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study.
Journal: European urology
Published: August 30, 2024
Enzalutamide and Quality of Life in Biochemically Recurrent Prostate Cancer.
Journal: NEJM evidence
Published: February 06, 2024
Treatment effect of semaglutide 2.4 mg on health-related quality of life from STEP 1 SF-6D derived from SF-36 with Australian weights.
Journal: Diabetes, obesity & metabolism
Published: August 24, 2023
A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma.
Journal: European urology oncology
Published: September 21, 2022
Subsidies to Increase Remote Pollution?
Journal: Science and engineering ethics
Published: January 25, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026